A cross-national performance comparison universal healthcare systems of Chile, Costa Rica, Italy, and Spain using OECD data

• Published in: Discover health systems 2024-04, Vol.3 (1), Article 20
• Main Authors: Zavaleta-Monestel, Esteban, Zovi, Andrea, Morales-Vallespín, Jorge, Martínez-Sesmero, José Manuel, Rojas-Barrantes, Zoe, Serrano-Arias, Bruno, Arguedas-Chacón, Sebastián, Díaz-Madriz, José Pablo, Villalobos-Madriz, Jorge Arturo, Langella, Roberto, Ortiz-Barboza, Adolfo, Ferrara, Francesco
• Format: Article
• Language: English
• Subjects: Health Care Management; Health Economics; Health Informatics; Health Services Research; Medicine; Medicine & Public Health; Practice and Hospital Management; Public Health
• ISSN: 2731-7501; 2731-7501
• DOI: 10.1007/s44250-024-00085-7

Objectives To analyze Organization for Economic Cooperation and Development (OECD) indicators for the Health Systems of Costa Rica, Spain, and Italy, focusing on year-to-year changes. Study design and methods Examining each country’s healthcare systems utilizes a value-for-money approach, aiming to outline their healthcare expenditures relative to the OECD average, while also assessing the value obtained from these investments. This involves contrasting reported indicator values for each country and the OECD average during a year close to the last decade’s outset (year 1) with data around 2020 (year 2). Results Results obtained are based on different indicators and the countries being examined. Costa Rica stood out with lowest healthcare investment, while Chile had the less population coverage for a set core of services. Italy and Spain achieved 100% healthcare coverage. All four regions reported decreased tobacco consumption in terms of non-medical determinants of health. Costa Rica showcased the highest vaccination coverage and experienced the most significant increase in this aspect within healthcare utilization. In the context of resource accessibility, waiting times from specialist assessment to treatment increased the most for hip replacement procedures in Chile, Costa Rica, Italy, and Spain. The Pharmaceutical Consumption analysis highlighted agents acting on the Renin-Angiotensin system as the most widely consumed category. Conclusion This analysis helps reveal the workings of diverse health systems, allowing us to pinpoint areas for potential improvement within each region. By examining the achievements and obstacles faced by other nations, policymakers and healthcare stakeholders acquire a valuable foundation on which to enact reforms.